- Home
- Automated
- List of product information
- CRAVIT OPHTHALMIC SOLUTION 1.5% W/V [SIN15047P]
CRAVIT OPHTHALMIC SOLUTION 1.5% W/V [SIN15047P]
Active ingredients: CRAVIT OPHTHALMIC SOLUTION 1.5% W/V
On this page
Product Info
CRAVIT OPHTHALMIC SOLUTION 1.5% W/V
[SIN15047P]
Product information
Active Ingredient and Strength | LEVOFLOXACIN HYDRATE - 15 MG/ML |
Dosage Form | SOLUTION, STERILE |
Manufacturer and Country | SANTEN PHARMACEUTICAL CO., LTD. NOTO PLANT - JAPAN |
Registration Number | SIN15047P |
Licence Holder | SANTEN PHARMACEUTICAL ASIA PTE. LTD. |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | S01AE05 |
INDICATIONS
Susceptible strains of Staphylococcus sp., Streptococcus sp., Streptococcus pneumoniae, Enterococcus sp., Micrococcus sp., Moraxella sp., Corynebacterium sp., Klebsiella sp., Enterobacter sp., Serratia sp., Proteus sp., Haemophilus influenzae, Haemophilus aegyptius [Koch-Weeks bacillus], Pseudomonas sp., Pseudomonas aeruginosa, Acinetobacter sp., and Propionibacterium acnes.
Blepharitis, dacryocystitis, hordeolum, conjunctivitis, tarsadenitis, keratitis (including corneal ulcer), and postoperative infections.
<Precautions related to Indications>
In order to avoid the emergence of resistant bacteria, bacterial susceptibility should be confirmed and treatment with this drug should be limited to the minimum period required for the eradication of the infection.
The efficacy of this product to methicillin-resistant Staphylococcus aureus (MRSA) has not been proven. Therefore, other drug having a potent anti-MRSA activity should be administered immediately to patients positively infected with MRSA and not showing any improvement of symptoms with this product.
DOSAGE AND ADMINISTRATION
Usually, instill 1 drop a time to the eye 3 times daily. The dosage may be adjusted according to the patient’s symptoms.
CONTRAINDICATIONS (This product is contraindicated in the following patients.)
Patients with a history of hypersensitivity to the ingredient of this product, ofloxacin or any quinolone antibiotics.
